Avanguard Surgery Center Avanguard Surgery Center Tarzana Location Contact Avanguard Surgery Center



Tel: (818) 344-0070 | Fax: (818) 344-0079
5620 Wilbur Ave. Suite 207
Tarzana, CA 91356-1351



Vladimir Grigoryants, M.D.


Surgery Specialties

Vladimir Grigoryants

Dr. Grigoryants is a board certified plastic surgeon specializing in cosmetic plastic surgery of the body and face. His practice is located at the Verdugo Hills Hospital in Glendale. Dr. Grigoryants provides his patients with effective and most advanced plastic surgery procedures in the safest possible environment. Patients come to Dr. Grigoryants from all over the United States as well as from other countries.

Dr. Grigoryants is following in the footsteps of his father and grandfather who were both surgeons.

After graduating from Dartmouth Medical School with Honors in Hanover, NH, he completed prerequisite training in General Surgery at the University of Michigan in Ann Arbor. Dr. Grigoryants accomplished additional fellowship training in Surgical Critical Care at the University of Michigan.

Dr. Grigoryants completed a busy and comprehensive training in Plastic and Reconstructive Surgery at the University of Virginia in Charlottesville, VA. Throughout his training, Dr. Grigoryants has been a recipient of many awards for academic excellence and his research contributions to the field of surgery. Dr. Grigoryants has conducted basic science and clinical research. His work has been featured in scientific journals and medical conferences

Medical Licenses

California Medical License - active


Hospital Staff Privileges

Verdugo Hills Hospital - Glendale, CA
Glendale Adventist Medical Center - Glendale, CA
Surgery Centers Beverly Hills and Encino, CA


Certification

American Board of Plastic Surgery
American Society of Plastic Surgeons


PUBLICATIONS - Book Chapter
  1. Vladimir Grigoryants, Narasinhma Dasika, Gilbert R. Upchurch. Aberrant Right Subclavian Artery. In: Upchurch GR and Henke PK, (eds.), Clinical Scenarios in Vascular Surgery. Philadelphia:Lippincott, Williams, Wilkins. 2004
Peer-reviewed Publications
  1. Vladimir Grigoryants, Sarah Abdulazadeh, Xin Quan, Kant Y. Lin. An expanded predictive model to assess the risk of complications following breast reconstruction In preparation.
  2. Vladimir Grigoryants, John A. Jane Jr., Kant Y. Lin,Salvage of a complicated meningomyelocele using Duragen and Alloderm. In print Pediatric Neurosurgery.
  3. Vladimir Grigoryants, Kant Lin. Pediatric chondrodermatitis nodularis helicis: case report and review of the literature. In Print. Journal of Craniofacial Surgery.
  4. Vladimir Grigoryants, Kevin K. Hannawa, Charles G. Pearce, Indranil Sinha, Gorav Ailawadi, Kristopher B. Deatrick, Derek T. Woodrum, Peter K. Henke, James C. Stanley, Matthew J. Eagleton, Gilbert R. Upchurch. Tamoxifen upregulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. .”Journal of Vascular Surgery. 2005;41:108-114.
  5. Vladimir Grigoryants, Matthew J. Eagleton, Gilbert R.Upchurch. Bilateral external carotid artery aneurysms. Vascular. 2004;12:387-389.
  6. Vladimir Grigoryants, Nicholas Watson, Gilbert Upchurch, James C. Stanley, Peter K. Henke. “Iliorenal bypass: indications and outcomes following 41 reconstructions Submitted to Annals of Vascular Surgery
  7. Kevin K. Hannawa, BS; Jonathan L. Eliason, MD; Derek T. Woodrum, MD; Charles G. Pearce, BA; Karen J. Roelofs, DVM; Vladimir Grigoryants, MD; Matthew J. Eagleton, MD; Peter K. Henke, MD; Thomas W. Wakefield, MD; James C Stanley, MD; Gilbert R. Upchurch, Jr, MD. L-Selectin–Mediated Neutrophil Recruitment in Experimental Rodent Aneurysm Formation. Circulation. 2005;112:241-247.
  8. Indranil Sinha, Jonathan L Eliason, Gorav Ailawadi, Kevin K Hannawa, Michael P Deogracias, Siddharth Bethi, John W Ford, Karen J Roelofs, Vladimir Grigoryants, Peter K Henke, James C Stanley, Gilbert R Upchurch. Early MT-1 MMP expression following following elastase exposure is associated with increased cleaved MMP-2 activity in experimental rodent aortic aneurysms. Surgery. 2004:136; 176-82.
  9. Mathew Eagleton, Vladimir Grigoryants, DA Peterson, , David M. Williams, Peter K. Henke, Thomas W. Wakefield, James Stanley, Gilbert Upchurch. Endovascular treatment of abdominal aortic aneurysm is associated with a low incidence of deep venous thrombosis. J Vasc Surg. 2002 Nov;36 (5):912-6.
  10. Gilbert R Upchurch, Jr., Peter K. Henke, Mathew J. Eagleton, Vladimir Grigoryants, Vita V. Sullivan, Thomas W. Wakefield, Lloyd A. Jacobs, Lazar J. Greenfield, James C. Stanley. Pediatric splanchnic arterial occlusive disease: Clinical relevance and operative treatment. J Vasc Surg 2002:35;860-867.
  11. Alik Farber, Vladimir Grigoryants, Diane M. Pallack, Jack L. Cronenwett, Richard J. Powell. Primary aortoduodenal fistula in a patient with a history of intravesical therapy for bladder cancer with bacillus Calmette-Guerin: review of primary aortoduodenal fistula without abdominal aortic aneurysm J Vasc Surg. 2001;33:868-73.
  12. Vladimir Grigoryants, Steven K. Sargent, Nicholas A. Shorter. Extralobar pulmonary sequestration receiving arterial supply from the innominate artery. Ped Rad. 2000;30:696-698.
PRESENTATIONS
  1. An expanded predictive model to assess the risk of complications following breast reconstruction. UVA Department of Plastic Surgery 50th Anniversary Meeting, Charlottesville, VA, June 23, 2006
  2. An expanded predictive model to assess the risk of complications following breast reconstruction. Southeastern Society of Plastic and Reconstructive Surgeons Meeting, Sea Island, GA, June 5-7, 2006.
  3. Tamoxifen upregulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. The 50th Frederick A. Coller Surgical Society Meeting, Nashville, TN, September 30- October, 1, 2004.
  4. Differential regulation of the superoxide dismutase family in the rodent aneurysm model and rat aortic smooth muscle cells. The 2004 Association for Academic Surgery, Houston, TX, November 11-13, 2004.
  5. Tamoxifen attenuates development of experimental abdominal aortic aneurysms by upregulating catalase. Society of Vascular Medicine and Biology. 15th Annual Scientific Sessions. Anaheim, CA, June 4-5, 2004.
  6. Tamoxifen attenuates development of experimental abdominal aortic aneurysms. Moses Gunn Annual Surgical Research Meeting. Ann Arbor, MI, April 30, 2004
  7. Iliorenal bypass: An effective alternative to aortorenal reconstruction in select patients with renovascular occlusive disease, Midwestern Vascular Surgical 26th Annual Meeting. Madison, WI, September 12-14, 2002.
  8. Iliorenal bypass: An effective alternative to aortorenal reconstruction in select patients with renovascular occlusive disease, Frederick A. Coller Surgical Society 48th Clinical Meeting Sea Island, GA, October 17-20, 2002.